BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2013
View Archived Issues
Phase III evaluation of a polymerase inhibitor for the treatment of drug-resistant hepatitis C
Read More
First-in-human results presented for the imaging agent [18F]FC-119S
Read More
Researchers at Biota Scientific Management present new antiviral agents
Read More
Hereditary fibrosing poikiloderma, a new condition caused by FAM111B gene mutations
Read More
Novel biomarker associated with suicide attempt in patients with MDD
Read More
Pfizer presents phase I results for a novel biosimilar of trastuzumab
Read More
Ocriplasmin receives initial recommendation for NHS reimbursement in U.K.
Read More
NeuroVive Pharmaceutical reports new collaboration and milestone payment from Sihuan
Read More
Natural derived polymer VS-501 may control serum phosphate in CKD
Read More
Derma Sciences reports data from pharmacokinetic study of DSC-127
Read More
Amgen and Cytokinetics expand license for omecamtiv mecarbil
Read More
Teprotumumab to be developed in new indication
Read More
Aphios and VivaCell to develop non-psychotropic cannabinoids
Read More
Ferrer completes phase III trial of ozenoxacin in impetigo
Read More
Roche presents new CB2 receptor agonists
Read More
Amgen reports topline results from phase III TRINOVA-1 trial
Read More
Constellation Pharmaceuticals prepares new EZH2 inhibitors for cancer
Read More
Chinese researchers patent novel HIV fusion inhibitors
Read More
Bioheart completes phase I ANGEL study
Read More
New DHODH inhibitors for malaria presented by Chinese researchers
Read More
Funding supports Madera's development of small-molecule drugs for Alzheimer's disease
Read More
Bill & Melinda Gates Foundation and European Commission partner
Read More
Nanobiotix cleared to begin study of NBTXR-3 for head and neck cancer
Read More
Exact Sciences completes PMA application for Cologuard screening test
Read More
Constella launched in Europe for the treatment of IBS-C
Read More